Skip to content

The American Consumer Institute

FacebooktwitterlinkedinrssvimeoFacebooktwitterlinkedinrssvimeo
Newsletter Sign Up ✉
VISIT : TheLostEconomy.com
  • Home
  • About Us
    • ACI Staff
    • Adjunct Experts
  • Blogs
  • Issues
    • Technology
    • Consumer Tips / Health
    • Internet Public Policy Issues
    • ENERGY / Environment
    • Finance / Insurance
    • Taxation
  • News
  • Podcast
  • Events
  • Donate
  • Contact

Coalition Letter Calls for the Use of Lower-Cost Biosimilars

Posted on November 24, 2020November 24, 2020 by Steve Pociask

Today, ACI signed a coalition letter calling on the U.S. Congress to encourage the use of lower-priced biosimilar medicines, which would save lives and reduce healthcare costs. The letter was sent to the U.S. House of Representatives and U.S. Senate leadership, and it is available here online.

FacebooktwitterredditlinkedinFacebooktwitterredditlinkedin
Posted in Health, Issues, NewsTagged biosimilars, congress, drugs

Post navigation

Sustainable Packaging: What Consumers Should Know This Thanksgiving
Webinar Video: Recycling: Paper, Plastic, or Metal?

THE AMERICAN CONSUMER INSTITUTE

:

CENTER FOR CITIZEN RESEARCH · COPYRIGHT © 2023

Privacy Policy | Terms of Use
  • Home
  • About Us
    • ACI Staff
    • Adjunct Experts
  • Blogs
  • Issues
    • Technology
    • Consumer Tips / Health
    • Internet Public Policy Issues
    • ENERGY / Environment
    • Finance / Insurance
    • Taxation
  • News
  • Podcast
  • Events
  • Donate
  • Contact